Co-Authors
This is a "connection" page, showing publications co-authored by Meletios Dimopoulos and Andreas Mentis.
Connection Strength
0.800
-
A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis. Microorganisms. 2021 Apr 11; 9(4).
Score: 0.235
-
Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. N Engl J Med. 2020 10 22; 383(17):1695.
Score: 0.226
-
Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19. Gynecol Oncol Rep. 2020 Aug; 33:100615.
Score: 0.224
-
Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays. Sci Rep. 2021 03 23; 11(1):6614.
Score: 0.058
-
Anti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study. Microorganisms. 2020 Nov 28; 8(12).
Score: 0.057